MEDIFIRST SOLUTIONS, INC. (OTCMKTS:MFST) touts that it has the magic bullet nearly every woman on the planet would like to have – with the Green Laser which is designed to restore and resurface our skin. The share price was flat for 2017 as of yesterday, but has been as much as 200% higher at points during the year proving that investing in skin is a tricky business.
The company updated shareholders announcing a Letter of Intent to acquire the exclusive licensing rights from Laser Lab Corp, a Florida Company, for its Green Laser used for anti-aging and aesthetics. Medifirst currently has the exclusive rights for sales and marketing for the anti-pain Infrared Red Laser, having successfully filed for FDA clearance. Subsequent to the completion of a definitive agreement, Medifirst plans to file for FDA clearance for the Green Laser before year’s end. The program for the Green Laser was designed to gently restore and lightly resurface the tissue of the skin. During the IRB studies, the Green Laser was successfully used on skin spots, wrinkles, acne, hyper-pigmentation, scars, skin detoxification, stretch marks and cellulite.
MEDIFIRST SOLUTIONS, INC. (OTCMKTS:MFST) believes that non-invasive and minimally invasive cosmetic procedures are showing tremendous growth in the healthcare sector. Additionally, Medifirst also believes that many doctors are creating extra revenue streams using these procedures. Doctors are motivated towards treatments that do not require or even accept insurance reimbursements. According to industry sources, the global market for aesthetic medical laser systems is forecast to reach US $8 to $10 billion by 2020, driven by the aging population’s shift towards minimally invasive procedures, and growing awareness over the safety of laser-based procedures.
“Aesthetic lasers are the Holy Grail of the laser industry considering the strength of the anti-aging and minimally invasive cosmetic industry. The Green Laser will provide a very effective alternative to big expensive laser machines and provides a mobile, easy-to-use and affordable solution for healthcare professionals seeking to enter the laser market.”, commented President Bruce J. Schoengood
Subscribe below and we’ll keep you on top of what’s happening before $MFST stock makes its next move.
$MFST 10-Day Chart Below:
Medifirst has engaged its FDA consulting firm to assist the Company to register its Infrared Time Machine Laser in Morocco and other foreign countries. Many countries have a lengthy process to register medical devices for distribution and the Company is actively working on the filings and various requests for information as a prerequisite for sales. Continued Schoengood, “We are very anxious to complete our first round of sales and we continue to work diligently to complete the due diligence process.”
Regarding domestic sales, Medifirst has engaged a team of experienced sales representatives for the US market which would include direct sales to medical professionals and engagements with medical distributors. Additionally, the company is very pleased that it’s laser is being used by top celebrity plastic surgeons in both New York and Beverly Hills.
Medifirst Solutions, Inc., in response to its Premarket Notification 510(k) submission for “The Time Machine” Series Laser, received clearance from the U.S. Food and Drug Administration (“FDA”) to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device.
The Time Machine Series Lasers Model TTML-8102000 – 810/830nm is intended for use in temporary relief of minor muscle and joint pain, stiffness, minor arthritis pain, muscle spasm, temporary increase in local blood circulation and temporary relaxation of muscles by means of topical elevated tissue temperature from infrared spectral emissions. Due to the decrease of inflammation, patients have seen immediate aesthetic improvements as well, such as in scar and incision healing. The hand-held laser device, with pin-point accuracy, often gives patients immediate results with no redness, swelling or down-time. This unique laser device offers medical professionals an affordable and effective tool to enhance their treatment protocols for their patients and provide new revenue streams for their practice.
The laser division will be operated out of Medifirst’s wholly owned subsidiary, Medical Lasers Manufacturer.
MEDIFIRST SOLUTIONS, INC. (OTCMKTS:MFST) is a good story with some trade-able metrics coming up in 2017, and know that shares will be volatile no matter what happens. Investing in triple zero sub penny stocks where the short term goal is to get to the penny status, which these shares have done in 2017.
Investing in TZSP (triple zero sub penny) is more art than science, but is becoming more popular as this bull market rotates down stream. MFST is one of these TZSP’s we follow, so stay tuned for more information on the magic bullet for your skin needs. For continuing coverage on shares of $MFST stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!